| Bioactivity | Tigulixostat (LC350189) is an orally active, non-purine selective xanthine oxidase inhibitor. Tigulixostat lowers the production of uric acid. Tigulixostat can be used for gout and hyperuricemia study[1]. | |||||||||
| Name | Tigulixostat | |||||||||
| CAS | 1287766-55-5 | |||||||||
| Formula | C16H14N4O2 | |||||||||
| Molar Mass | 294.31 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Seonghae Yoon, et al. Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects. Drug Des Devel Ther. 2015 Aug 31;9:5033-49. |
Tigulixostat
CAS: 1287766-55-5 F: C16H14N4O2 W: 294.31
Tigulixostat (LC350189) is an orally active, non-purine selective xanthine oxidase inhibitor. Tigulixostat lowers the pr
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.